高能環境(603588.SH):玉禾田首次公開發行股票申請獲中國證監會核准
格隆匯1月6日丨高能環境(603588.SH)公佈,近日,公司全資子公司深圳市鑫卓泰投資管理有限公司(以下簡稱“深圳市鑫卓泰”)收到玉禾田環境發展集團股份有限公司(以下簡稱“玉禾田”)通知,玉禾田A股首次公開發行股票申請於2019年12月27日獲得中國證券監督管理委員會《關於核准玉禾田環境發展集團股份有限公司首次公開發行股票的批覆》文件核准。
截至本公告日,公司通過深圳市鑫卓泰間接持有玉禾田2000萬股股份,佔其發行前總股本的19.27%,該部分股份自玉禾田股票上市之日起12個月內不得轉讓。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.